Introduction {#s1}
============

Generally, meningiomas originate from the dura mater; however, some cases originate from the Sylvian fissure and show non-dural attachment. These cases can be easily missed preoperatively or may be misdiagnosed. Atypical meningioma is a distinct meningioma subtype and accounts for a small proportion of meningiomas with poor prognosis ([@B1]). At present, 38 cases of Sylvian fissure meningiomas have been reported ([@B2]--[@B32]), and four cases presented an atypical type ([@B19], [@B22], [@B25], [@B30]), but none were non-enhanced lesions ([@B30]). In this report, we describe a patient who presented with an intracranial mass in the right insula lobe, which was clinically diagnosed as a low-grade glioma based on the results of preoperative neuroimaging, with a subsequent revised diagnosis of meningioma confirmed by postoperative histopathology. In contrast with previous reported cases, our case presented characteristic non-enhancement of the meningioma lesion on contrast-enhanced magnetic resonance imaging (MRI), which is unique. In addition, we have reviewed the relevant literature and summarized the major findings herein to improve the awareness of Sylvian fissure meningiomas among clinicians for the differential diagnosis of Sylvian fissure lesions.

Case Presentation {#s2}
=================

The patient was a 30-year-old homemaker with a 2-year history of seizures before admission. She had previously been treated with a routine antiepileptic (sodium valproate; 1,000 mg per day) for 3 months; however, the drug was weaned off because of its side effect (weight gain). Subsequently, she was prescribed lamotrigine (200 mg per day) and topiramate (75 mg per day) for seizure control, but continued to have occasional seizures, once or twice a month. She had no other neurological deficit or past medical history, and results of systemic examinations were normal. She had no family history of hereditary diseases. Electroencephalography performed after admission detected epileptiform activity in the right cerebral hemisphere. Computerized tomography (CT) demonstrated a calcific lesion in the right Sylvian fissure and posterior part of the insula ([Figure 1A](#F1){ref-type="fig"}). An MRI scan revealed a lesion in the right insular lobe without any dural attachment, which was primarily hypointense on both T1- and T2-weighted MRI ([Figures 1B,C](#F1){ref-type="fig"}). Additionally, the lesion appeared hypointense on susceptibility-weighted imaging ([Figure 1D](#F1){ref-type="fig"}), with no obvious enhancement despite administration of gadolinium contrast ([Figures 1E, F](#F1){ref-type="fig"}). The results of all preoperative laboratory tests were within normal ranges. Preoperatively, low-grade glioma, including oligodendroglioma, and diffuse astrocytoma, was suspected.

![**(A)** The Computed tomography demonstrated the calcification in right Sylvian fissure and posterior part of insula. **(B,C)** MRI scans revealed a lesion without dural attachment located in right insular lobe which was mainly hypointense on both T1-weighted and T2-weighted. **(D)** Lesion showed hypointense on susceptibility weighted imaging. Enhanced MRI showed no obvious enhancement after gadolinium administration in axial **(E)** and coronal **(F)** position.](fonc-10-00427-g0001){#F1}

With this provisional diagnosis, the patient was referred for surgical management and underwent a right temporal craniotomy for gross total resection of the tumor and for seizure control. Upon opening the dura and separating the Sylvian fissure, a gray-white lesion (diameter, about 25^\*^20 mm) was observed. It had a relatively elastic consistency and the mass partially invading the brain parenchyma of the insula, was densely adhered to the branches of the medial cerebral artery (MCA), and had partial calcification. Intraoperatively, despite careful micro-dissection, the MCA perforators were mildly damaged. Ultimately, several surgical specimens of the excised tumor were sent for histopathological analysis. Postoperatively, the results of histopathological examinations revealed a World Health Organization (WHO) grade II meningioma of atypical type ([Figures 2A--D](#F2){ref-type="fig"}). Immunohistochemical examinations revealed negative immunoreactivity for Ki-67, progesterone receptor, p53, epithelial membrane antigen, and positive immunoreactivity for vimentin, and somatostatin receptor 2.

![**(A)** The tumor tissue arranged in swirl structure to form the meningeal corpuscle. **(B)** Psammoma bodies. **(C)** The meningeal corpuscles invade normal brain tissue. **(D)** GFAP staining show brain tissue (+) and meningeal corpuscles (-). Postoperative CT **(E)** and MRI **(F,G)** showed tumor gross total resection.](fonc-10-00427-g0002){#F2}

Postoperatively, the patient regained consciousness with a mild clinical symptom of hemiplegia in her left limbs, which lasted for nearly 2 weeks but improved gradually with rehabilitation therapy. A follow-up gadolinium-enhanced MRI (postoperative 2 weeks) showed complete total excision of the tumor ([Figures 2E--G](#F2){ref-type="fig"}). The patient presented no other postoperative neurological deficit or seizure recurrence for approximately a year and a half. An MRI scan will be performed annually to continuously monitor for any evidence of tumor recurrence.

Discussion {#s3}
==========

Meningiomas are the second most common primary central nervous system tumors (CNST), accounting for approximately one-third of the primary CNST cases ([@B33], [@B34]). They are postulated to originate from the arachnoid cap and meningothelial cells, which are present in the arachnoid layer of the meninges or Pacchionian granulation, and typically display dural attachment. Occasionally, the arachnoid cap cells can appear in the pia mater of the Sylvian fissure or Virchow-Robin space along the MCA or its branches ([@B23], [@B31]) ([Figure 3](#F3){ref-type="fig"}). Our patient presents an additional case of Sylvian fissure meningioma with unusual imaging characteristics and a rare atypical subtype.

![Schematic diagram of the origin of Sylvian fissure meningiomas.](fonc-10-00427-g0003){#F3}

The mean onset age of typical meningiomas is about 55 years, and the incidence increases with age, with women having a higher morbidity than men ([@B34]). However, the clinical characteristics of Sylvian fissure meningiomas are different. A retrospective analysis of 38 \[25 men (65.8%) and 13 female (34.2%)\] patients with Sylvian fissure meningiomas reported from 1938 to 2019 ([Table 1](#T1){ref-type="table"}) revealed that the average onset age is about 22.5 ± 17.4 years. Seizure was the major symptom of Sylvian fissure meningiomas (65.8%, 25 patients). Other reported symptoms included headache (39.5%, 15 patients) and hemiparesis (18.4%, 7 patients). Rare instance of initial symptom included visual impairment (2.6%, 1 patient), incidental (2.6%, 1 patient), and dizziness (2.6%, 1 patient). The incidence of seizures in patients with Sylvian fissure meningiomas (65.8%) was reported to be higher than those with common supratentorial meningiomas (29.2%) ([@B35]). Generally, seizure frequency depends on tumor location, and the limbic and temporal lobe had the lowest threshold for producing a seizure. Also, hypoxia and metabolic imbalances caused by tumor invasion and extrusion were the potential etiological mechanisms ([@B36]).

###### 

Summary of Sylvian fissure meningiomas up to October 31, 2019.

  **References**                  **Age/Sex**   **Clinical features**                 **Imaging features**                                                                        **Removal**                                      **Histopathology**      **Follow-up**
  ------------------------------- ------------- ------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------ ----------------------- ----------------------------
  Cushing et al. ([@B2])          8/M           Epilepsy                              N/A                                                                                         Subtotal                                         Psammomatous            5y: died
                                  48/F          Epilepsy                              N/A                                                                                         Subtotal                                         Psammomatous            1d: died
  Barcia-Goyanes et al. ([@B3])   20/F          Epilepsy                              N/A                                                                                         N/A                                              Psammomatous            N/A
  Mori et al. ([@B4])             23/M          Epilepsy                              N/A                                                                                         Subtotal                                         Transitional            N/A
  Saito et al. ([@B5])            31/F          Epilepsy                              Hyperdense lesion in CT                                                                     Gross total                                      Psammomatous            N/A
  Tsuchida et al. ([@B6])         46/M          Headache                              N/A                                                                                         Gross total                                      Psammomatous            4y: relapse-free
  Awa et al. ([@B7])              16/M          Headache                              N/A                                                                                         Gross total                                      Meningothelial          2y: relapse-free
  Okamoto et al. ([@B9])          27/F          Headache                              N/A                                                                                         Gross total                                      Fibroblastic            5y: died
                                  35/F          Headache and visual impaired          Severe edema, hyperdense, and homogeneous lesion in CT                                      Gross total                                      Fibroblastic            N/A
  Drake et al. ([@B8])            3/F           Headache                              N/A                                                                                         Gross total                                      Malignant               N/A
  Hirao et al. ([@B10])           34/F          Epilepsy                              Homogeneous enhancement in CT                                                               Gross total                                      Fibroblastic            N/A
  Silbergeld et al. ([@B11])      4/F           Epilepsy                              Homogeneous enhancement in CT                                                               Subtotal, radiation therapy                      Meningothelial          N/A
  Cho et al. ([@B12])             2/M           Epilepsy and hemiparesis              Severe edema, hyperdense with homogeneous lesion in CT                                      Gross total                                      Transitional            2y: relapse-free
  Graziani et al. ([@B13])        19/M          Headache and hemiparesis              Moderate edema, calcifications, Hypointense in T1 and T2                                    Gross total                                      Psammomatous            N/A
  Mori et al. ([@B15])            12/M          Headache                              Slight edema, well-enhanced tumor in CT and MRI                                             Gross total                                      Transitional            1y: relapse-free
  Chiocca et al. ([@B14])         26/F          Epilepsy                              Slight edema, hypointense and homogeneous in T1 and T2                                      Gross total                                      Fibroblastic            N/A
  Matsumoto et al. ([@B16])       62/F          Epilepsy                              Hypointense in T1 and T2                                                                    Gross total                                      Psammomatous            N/A
  Cooper et al. ([@B17])          4/M           Headache                              Severe edema, heterogeneous intensity in T1 and T2                                          Gross total                                      Transitional            1y: relapse-free
  Mitsuyama et al. ([@B18])       1/M           Epilepsy                              Well-enhanced tumor in CT and MRI                                                           Gross total                                      Fibroblastic            N/A
  Kaplan et al. ([@B19])          11/M          Epilepsy                              Isointense in T1 and heterogeneous intensity in T2                                          Gross total                                      Atypical                N/A
  Chang et al. ([@B20])           35/M          Epilepsy                              Severe edema, isointense, and homogeneous in T1 and T2                                      Subtotal, gamma-knife                            Transitional            N/A
  Mclver et al. ([@B21])          23/M          Epilepsy                              Heterogeneous intensity in T1 and T2                                                        Subtotal                                         Chordoid                17m: stable residual tumor
  Samson et al. ([@B23])          6/M           Epilepsy                              Calcification, edema, heterogeneous enhancement, hypointense on T1 and hyperintense on T2   Gross total                                      N/A                     4y: relapse-free
  Cecchi et al. ([@B22])          23/M          Headache and hemiparesis              Moderate edema, heterogeneous intensity in T1 and T2                                        Subtotal, radiation therapy                      Atypical                2y: stable residual tumor
  Ma et al. ([@B25])              53/M          Epilepsy                              Homogeneous enhancement, edema                                                              Subtotal, gamma-knife                            Atypical                2y: stable residual tumor
  Chae et al. ([@B24])            69/M          Incidental                            Calcification, edema, heterogeneous intensity in T2, heterogenous enhancement               Subtotal                                         Psammomatous            N/A
  Aras et al. ([@B26])            15/M          Epilepsy                              Homogeneous enhancement, hypointense on T1 and iso-hypointense on T2, mild edema            1st surgery: subtotal 2nd surgery: gross total   Fibroblastic            3y: relapse-free
                                  28/M          Epilepsy and hemiparesis              Heterogenous enhancement, hypointense on T1 and heterogeneous intensity on T2, edema        1st surgery: subtotal 2nd surgery: gross total   Meningothelial          5y: relapse-free
  Kim et al. ([@B27])             43/M          Epilepsy                              Minimal calcification, Isointense in T1 and T2, ring like enhancement, edema                Subtotal                                         Lymphoplasmacyte-rich   4y: stable residual tumor
  Fukushima et al. ([@B28])       10/M          Epilepsy                              Heterogeneous enhancement                                                                   Subtotal                                         Sclerosing              1y: stable residual tumor
  Donovan et al. ([@B29])         11/M          Epilepsy                              Calcification, homogenous enhancement                                                       Gross total                                      Transitional            10y: relapse-free
                                  7/M           Epilepsy and headache                 Calcification, homogenous enhancement                                                       1st surgery: subtotal 2nd surgery: subtotal      Fibroblastic            2y: stable residual tumor
                                  16/F          Epilepsy                              Partial calcification, minimal enhancement                                                  Subtotal                                         Meningothelial          5y: stable residual tumor
  Brogna et al. ([@B30])          32/M          Headache and dizziness                Isointense on T1 and T2, homogenous enhancement                                             Gross total                                      Atypical                3y: relapse-free
  Yamagishi et al. ([@B32])       32/M          Headache                              Isointense on T1 and T2, homogenous enhancement                                             Gross total                                      Transitional            6m: relapse-free
  Amirjamshidi et al. ([@B31])    7/F           Headache and hemiparesis              Calcification, edema, isointense on T1 and T2, vivid enhancement                            Gross total                                      Meningothelial          13y: relapse-free
                                  5/F           Headache, epilepsy, and hemiparesis   Isointense on T1 and T2, homogenous enhancement                                             Gross total                                      Meningothelial          5y: relapse-free
                                  7/M           Headache, epilepsy, and hemiparesis   Isointense on T1, homogenous enhancement                                                    Gross total                                      Meningothelial          2y: relapse-free

The majority of common meningiomas are WHO grade I, with approximately 16.9% cases being atypical (WHO grade II) ([@B37]). However, the proportion is expected to rise according to the newly recommended WHO 2016 criteria for the classification of atypical meningioma ([@B38]). Sylvian fissure meningiomas comprise three types of WHO grades, and previously reported cases were histologically diagnosed as psammomatous (8 cases, 21.1%), transitional (7 cases, 18.4%), meningothelial (7 cases, 18.4%), fibroblastic (7 cases, 18.4%), atypical (4 cases, 10.5%), chordoid (1 case, 2.6%), sclerosing (1 case, 2.6%), lymphoplasmacyte-rich (1 case, 2.6%), and malignant (1 case, 2.6%). The arachnoid cells in all of these cases can manifest divergent differentiation. Presence of brain invasion, which was added to the histological criteria, alone can aid the diagnosis of atypical meningiomas according to the 2016 WHO classification of CNSTs ([@B38]). Invasion of the brain parenchyma in our case confirmed a final diagnosis of atypical type meningioma with WHO II grade, which is the fifth case reported till date.

The main radiological characteristics of meningiomas generally include extra-axial occupation and dura mater attachment (dural tail sign). Contrarily, radiological imaging features of Sylvian fissure meningiomas have differential characteristics, such as intra-axial mass without dural attachment. It is extremely difficult to differentiate Sylvian fissure meningioma from other intracranial masses, such as low-grade glioma, teratoma, metastasis, cavernous hemangioma, tuberculous granuloma, etc. The previously reported 38 cases of Sylvian fissure meningiomas frequently showed hypointense or isointense lesions on T1- and T2-weighted MRI, with homogeneous or heterogeneous enhancement after contrast administration. Some cases also showed calcification or edema on CT and MRI scans, but these features were non-specific. Interestingly, the tumor in our case presented obvious calcification with negligible enhancement on the preoperative contrast-enhanced MRI scan, which significantly complicated the preoperative diagnosis. Meningiomas without enhancement have rarely been reported previously. Kubota et al. ([@B39]) and Zhang et al. ([@B40]) reported two cases of non-enhancement meningioma, due to the cystic or necrotic changes and distinctive pathological features. We considered that the tumor calcification, as a large number of psammoma bodies are found in pathology, result in non-enhancement in our case.

It is well-acknowledged that the progressive growth and enlargement of typical meningiomas can oppress or enclose the arteries. However, owing to the layer of arachnoid membrane between the blood vessels and tumors, it is relatively easy to intraoperatively discern and separate the meningiomas from the adjacent arteries. Because of the close relationship between the Sylvian fissure meningiomas with the MCA and its branches, blood vessels are more likely to be damaged during resection surgeries. In our case, a branch of the MCA was injured intraoperatively despite careful micro-dissection, and the patient had a mild cerebral infarction postoperatively. Fortunately, the patient recovered without any obvious neurological impairment after an adequate recovery period and remained seizure free for about a year and a half postoperatively. According to the previously reported cases, 22 (57.9%) patients achieved gross total resection in the first attempt and showed favorable outcomes with a relapse-free status (92.3%, 12/13 patients, some patients had no follow-up data) at follow-up even after several years. Of the 15 patients who underwent subtotal resection of tumor, three patients underwent a secondary surgery, and four patients accepted subsequent radiation or gamma-knife therapy. However, the residual tumors in all 15 patients showed no sign of further progression. Patients at risk of serious postoperative complications with gross total excision surgery can be recommended for radiation or gamma-knife therapy ([@B11], [@B20], [@B22], [@B25]). Atypical meningiomas are intermediate-grade tumor with a relatively greater risk of recurrence, requiring longitudinal monitoring by sequential radiological imaging. Optionally, radiation therapy can be used if required. The patient was satisfied with the overall treatment course, operation, and intensive nursing; moreover, her seizures are now well under control.

Conclusion {#s4}
==========

Sylvian fissure meningiomas are rare, and a preoperative diagnosis is difficult without adequate knowledge of the case. Due to the special origin, Sylvian fissure meningiomas generally present non-dural attachment and have a close relationship with the MCA ([@B30]). Tumor onset usually occurs at a young age and seizures are the most common initial symptom. Sylvian fissure meningiomas have multiple pathological types and effective treatment can ensure a favorable prognosis. However, the tumor should be carefully resected in cases with arterial adherence to avoid collateral artery injuries and postoperative infarction. This study is the fifth report of a rare case of an atypical Sylvian fissure meningioma with unusual presentations on preoperative radiological examination. The case report adds new knowledge to the existing literature and will help to remind clinicians of the rare presentations of atypical meningioma.
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